PositiveID Accelerates Prototype Development of Its Firefly Dx System for Real-Time Molecular Diagnostic Testing

DELRAY BEACH, Fla., Sept. 23, 2014 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that it is accelerating the prototype development of its Firefly Dx system, a handheld, real-time PCR (polymerase chain reaction) system designed to provide molecular diagnostic results in less than 20 minutes at the point of need. To advance the development, PositiveID has engaged

Source: globenewswire.com

See on Scoop.itBiodefense News

Leave a Reply